Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Israel's Teva Buys Allergan's Generics Business For $40 Billion | Fortune
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
The Unlikely Source of a Healthtech Revolution - Bloomberg
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva's job-cut tally could touch 10K: report | FiercePharma
Teva is on the prowl and its investors are taking notice
New York jury holds drug firm Teva liable in opioid crisis
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case | Time
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - BNN Bloomberg
Teva Must Face Amrix Developer's $97.5 Million Contract Suit
Pfizer gets $2.15 billion settlement
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Israeli Drugmaker Teva in Talks to Help Produce Covid-19 Vaccines
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/OFHUIOHUNRDDZEATIQ3XXXHYQM.jpg "Teva to repay $1.2B for Cephalon's conspiring with generic firms")